ESR1 and breast carcinoma: In this study, we examined the effects of miR-214 on sensitivity of breast cancer cells to TAM and FUL in the ER+ and estrogen/TAM-sensitive MCF7 cells and antiestrogen-resistant MCF7/LCC9 cells.